Stephen D. PhinneyMD, PhD · physician-scientist; co-founder and former Chief Medical Officer, Virta Health
Not on its own. Get particle number and ApoB, and read the rise against the whole risk panel before you act on it.
What it rests onIn his company's one-year trial (Bhanpuri et al. 2018, reported in the Virta post) calculated LDL cholesterol rose slightly while total LDL particle number and ApoB were unchanged and the distribution shifted toward larger particles, alongside a large fall in triglycerides, a rise in HDL and a ten-year ASCVD risk score change of -11.9 percent. His mechanical point is that standard-panel LDL is calculated rather than measured, and a large change in triglycerides skews the calculation, so on this diet the calculated number is least trustworthy exactly when it moves. The evidence is his own company's trial: Virta Health sponsored it, it tested Virta's programme, and he is a founder and employee offered stock options.
Source: virtahealth.com ↗
